Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Robert Hegele MD, FRCPC

Robert A. Hegele MD, FRCPC

Jacob J. Wolfe Distinguished Medical Research Chair, Martha Blackburn Chair in Cardiovascular Research, Distinguished University Professor of Medicine and Biochemistry, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada

Robert Hegele is an endocrinologist and lipidologist who cares for > 2500 patients at the lipid clinic at University Hospital, London, Ontario, Canada. He holds the Wolfe Distinguished Medical Research Chair, the Edith Schulich Vinet Chair in Human Genetics and the Blackburn Chair in Cardiovascular Research at the Schulich School of Medicine and Dentistry, Western University.   His lab discovered the molecular genetic basis of >20 human diseases, including hepatic lipase deficiency and two forms of familial partial lipodystrophy. He holds a Foundation grant from Canadian Institutes of Health Research and has received uninterrupted operating support since 1990. He was first in North America to use 5 medications that are now routinely prescribed to treat high cholesterol or diabetes. He has published 760 papers, which have been cited >30,000 times in the medical literature, and is in the Clarivate top 1% of highly cited scientists. The website in 2019 ranked him #1 globally in the area of “hypertriglyceridemia” and #1 for “disorders of lipid metabolism”. In 2019 he received the American Heart Association George Lyman Duff Memorial Award in Atherosclerosis Research. He has co-authored many clinical practice guidelines for cholesterol, blood pressure and diabetes. He has trained numerous physicians, medical students and graduate students.


Dr. Hegele receives consulting fees from Acasti, Akcea/Ionis, Amgen, HLS Therapeutics, Regeneron and Sanofi.